Activity profiles of two hyperforin-containing hypericum extracts in behavioral models
- PMID: 9684944
- DOI: 10.1055/s-2007-979342
Activity profiles of two hyperforin-containing hypericum extracts in behavioral models
Abstract
The behavioral activity profile of a therapeutically used alcoholic hypericum extract containing hyperforin (4.5%) in rodent models was compared with that of an experimental CO2 extract devoid of hypericines but highly enriched in hyperforin (38.8%). The antidepressant activities of 50, 150 and 300 mg/ kg/day of the alcoholic extract were similar to those of 5, 15 and 30 mg/kg/day respectively of the CO2 extract. The ethanol extract in the same dose range potentiated dopaminergic behavioral responses, whereas these effects were either absent or less pronounced in the CO2 extract treated groups. By contrast, serotoninergic effects of the CO2 extract were more pronounced than those of the alcoholic extract. These and various other observations made during the study confirm that although the antidepressant action of hypericum extracts depends on their hyperforin contents, their spectrums of central activity are due to other component(s). Our working hypothesis that hyperforin and serotoninergic mechanisms are involved in the therapeutically observed antidepressant activities of hypericum extracts is in agreement with these observations.
Similar articles
-
Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility.Pharmacopsychiatry. 1998 Jun;31 Suppl 1:7-15. doi: 10.1055/s-2007-979340. Pharmacopsychiatry. 1998. PMID: 9684942
-
Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).Pharmacopsychiatry. 1998 Jun;31 Suppl 1:30-5. doi: 10.1055/s-2007-979343. Pharmacopsychiatry. 1998. PMID: 9684945
-
Hyperforin as a possible antidepressant component of hypericum extracts.Life Sci. 1998;63(6):499-510. doi: 10.1016/s0024-3205(98)00299-9. Life Sci. 1998. PMID: 9718074
-
The antidepressant mechanism of Hypericum perforatum.Life Sci. 2004 Jul 16;75(9):1021-7. doi: 10.1016/j.lfs.2004.04.005. Life Sci. 2004. PMID: 15207650 Review.
-
Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients.Clin Pharmacokinet. 2006;45(5):449-68. doi: 10.2165/00003088-200645050-00002. Clin Pharmacokinet. 2006. PMID: 16640452 Review.
Cited by
-
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7500-2. doi: 10.1073/pnas.130155097. Proc Natl Acad Sci U S A. 2000. PMID: 10852961 Free PMC article.
-
Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.J Clin Immunol. 2004 Nov;24(6):623-36. doi: 10.1007/s10875-004-6248-z. J Clin Immunol. 2004. PMID: 15622447
-
The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism.Nucl Recept Signal. 2009;7:e001. doi: 10.1621/nrs.07001. Epub 2009 Jan 16. Nucl Recept Signal. 2009. PMID: 19240808 Free PMC article. Review.
-
The Biochemical and Genetic Basis for the Biosynthesis of Bioactive Compounds in Hypericum Perforatum L., One of the Largest Medicinal Crops in Europe.Genes (Basel). 2020 Oct 16;11(10):1210. doi: 10.3390/genes11101210. Genes (Basel). 2020. PMID: 33081197 Free PMC article. Review.
-
Role of hyperforin in the pharmacological activities of St. John's Wort.CNS Drug Rev. 2004 Fall;10(3):203-18. doi: 10.1111/j.1527-3458.2004.tb00022.x. CNS Drug Rev. 2004. PMID: 15492771 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical